Valtrex Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

valtrex

glaxosmithkline nz limited - valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg;  ; valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg - film coated tablet - 500 mg - active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg   excipient: carnauba wax colloidal silicon dioxide crospovidone edible ink blue brilliant 5312 magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water   active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water   - · valtrex is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.